Recombinant human erythropoietins: very rare risk of severe cutaneous adverse reactions (SCARs)

2018-01-09T10:27:04+00:00

Recombinant human erythropoietin (r-HuEPO) treatment has been associated with very rare cases of life-threatening severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and toxic epidermal necro…